Navigation Links
Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
Date:6/12/2012

EDISON, N.J., June 12, 2012 /PRNewswire/ -- Oriel STAT A MATRIX has announced the appointment of Dr. Paul Landesman as Managing Director, Medical Devices and Life Sciences Practice.

In his new position, Dr. Landesman will be responsible for strategic leadership and managerial oversight of this practice.  He will also provide consultative oversight for the firm's delivery of regulatory, quality assurance, cost optimization, and best business practices for organizations in the pharmaceutical, medical device, combination products, and biotechnology sectors.  

Oriel STAT A MATRIX CEO Alan Marash noted, "Dr. Landesman's depth of industry knowledge and experience adds enormous strength to the firm's medical devices and life sciences practice. We look forward to having Paul identify new growth opportunities and shepherd the firm to the next level of knowledge leadership, customer service, performance, and professionalism."

Commenting on his new role at Oriel STAT A MATRIX, Dr. Landesman added, "Oriel STAT A MATRIX has succeeded in building a strong and well-recognized practice in the life sciences community, providing an excellent platform for future growth to meet the compliance and business requirements for our customers and the patients whom they serve."

Dr. Landesman joins Oriel STAT A MATRIX from Allergan Medical in Santa Barbara, CA, where he was a Senior Director of Quality Systems and Risk Management.   He has over 30 years of experience in quality, regulatory affairs, and patient safety in the medical device, pharmaceutical, and biotech industries, and has worked with the FDA and other global regulatory bodies in a wide variety of capacities.  In addition to his most recent position at Allergan, Dr. Landesman has worked with Abbott Laboratories, Hospira, and Amgen.

Dr. Landesman holds a BS in chemistry from the University of Massachusetts‒Dartmouth and a PhD in Medicinal Chemistry from the University of Buffalo.  He also served as Associate Director of the Clinical Laboratories at The Ohio State University Hospitals.  

About Oriel STAT A MATRIX

Since 1968, Oriel STAT A MATRIX has provided organizations with best-in-class performance improvement training and consulting—including FDA-regulated services, implementation of ISO 9000, and continual improvement methods such as Lean Six Sigma—that enhance financial results and customer satisfaction.   

In 1978, US FDA regulators chose Oriel STAT A MATRIX to work with the agency in rewriting the good manufacturing practice (GMP) regulations, the precursor to the current GMP (CGMP)/quality system regulations (QSR). The firm was then selected to train FDA compliance investigators in the new regulations. Since then, Oriel STAT A MATRIX has been a global leader in implementing quality and regulatory requirements at pharmaceutical, biotechnology, and medical device companies, as well as at hospitals and other healthcare provider organizations.    

Oriel STAT A MATRIX has offices in more than 18 countries and a diversified customer base that spans the globe and represents every economic sector.

For further information about Oriel STAT A MATRIX, please visit www.orielstat.com or call 732.548.0600.


'/>"/>
SOURCE Oriel STAT A MATRIX
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
2. Global BioClinical Welcomes Jennifer Maas as Senior Consultant
3. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
4. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
5. Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare
6. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
7. Post-Recession, the Global Market for Surgical Equipment Picks Up Speed, Particularly In China and Emerging Economies
8. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
9. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
10. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
11. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2020)... ... July 03, 2020 , ... By Heidi Jean Doerfert , During ... our homes for cover, Assuaged, Inc. is going full speed ahead. Founders ... globe this year to get their feet wet in marketing, social media content, research, ...
(Date:7/2/2020)... (PRWEB) , ... July 02, 2020 , ... ... wholesale pharmaceutical distributor, is pleased to announce its donation of more than $190,000 ... Michigan Department of Health and Human Services. As extreme medical shortages continue to ...
(Date:6/28/2020)... , ... June 28, 2020 , ... ... health. New studies substantiate the effectiveness of oral-care probiotics to maximize teeth ... While the science behind both is simple – utilizing naturally occurring positive ...
Breaking Medicine Technology:
(Date:7/2/2020)... Conn. (PRWEB) , ... July 02, 2020 , ... ... of many businesses, including dental offices for non-emergency work. In conjunction with the ... reopening guidelines for Connecticut dental practices in mid-May. , Due to safety ...
(Date:7/1/2020)... ... 2020 , ... Psilera Bioscience (“Psilera”), a Florida ... its core executive team. The co-founders Drs. Jackie Salm and Chris Witowski have ... distinguished researchers within the cannabis industry. They are joined by pharmaceutical and corporate ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... in the revision and redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for ... Basins. PHTA is seeking member participation on the PHTA-7 Standard Writing Committee (SWC) ...
(Date:6/28/2020)... TEMECULA, Calif. (PRWEB) , ... June 26, 2020 ... ... been tougher. Inland Detox, the Inland Empire’s premier residential addiction treatment center, proudly ... of services that now includes special preparation for recovery in a world affected ...
(Date:6/28/2020)... ... June 27, 2020 , ... ... the first online, full-day educational conference in the organization’s history. The online conference ... muscular dystrophy (FSHD), which was cancelled this year due to COVID-19. Nearly 300 ...
Breaking Medicine News(10 mins):